Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.

被引:0
|
作者
Krzyzanowska, Agnieszka
Barron, Stephen
Higgins, Debra
Loughman, Tony
Sheehan, Katherine
Wang, Angel Chan-Ju
Fender, Bozena
McGuire, Leah M.
Galvin, David Jonathan
O'Neill, Amanda
Fay, Joanna
O'Grady, Anthony
O'Leary, Des
Watson, William
Bjartell, Anders
Gallagher, William M.
机构
[1] Lund Univ, Div Urol Cancers, Fac Med, Lund, Sweden
[2] OncoAssure Ltd, Dublin, Ireland
[3] RCSI Educ & Res Ctr, Dublin, Ireland
[4] St Vincents Hosp Grp, Dublin, Ireland
[5] Univ Coll Dublin, Dublin, Ireland
[6] Beaumont Hosp, Dept Histopathol, Dublin, Ireland
[7] OncoAssure Ltd, Dublin, Ireland
[8] Sch Med & Med Sci, Dublin, Ireland
[9] Skane Univ Hosp, Malmo, Sweden
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
374
引用
收藏
页数:1
相关论文
共 11 条
  • [11] Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3+3 and 3+4 Early Stage Prostate Cancer
    Roth, Joshua A.
    Ramsey, Scott D.
    Carlson, Josh J.
    ONCOLOGIST, 2015, 20 (12): : 1355 - 1364